INTCO Medical reports 40.6% H1 2026 revenue growth and expands global disposable glove capacity to 107 billion pieces
Executive summary: INTCO Medical reported H1 2026 revenue of RMB 6.91 billion (≈USD 1.03 billion), a 40.6% increase, and announced an expansion of its global disposable glove production capacity to 107 billion pieces. The result underscores robust demand for disposable gloves in the healthcare sector and indicates a major capacity increase that could influence market pricing and raw‑material demand.
Who is involved: INTCO Medical (stock code 300677.SZ), its shareholders, healthcare institutions, and suppliers of nitrile/latex raw materials.
Likely next: Continued rollout of the new capacity through Q4 2026, monitoring of glove market supply‑demand balance, and further ESG‑related disclosures.
INTCO Medical, a China‑based glove manufacturer, announced first‑half 2026 revenue of RMB 6.91 billion (≈USD 1.03 billion), up 40.6% year‑on‑year, and disclosed plans to raise its worldwide disposable glove production capacity to 107 billion units. The simultaneous release of the same figures in a Dutch‑language press release confirms the consistency of the reported numbers. The move reflects sustained demand for medical gloves and signals a significant scaling of the company’s supply‑chain footprint.
Timeline
- — INTCO Medical meldet für das erste Halbjahr 2026 ein Umsatzwachstum von 40,6 % und baut die weltweit größte Produktionskapazität für Einweghandschuhe auf 107 Milliarden Stück aus (PR Newswire)
- — INTCO Medical rapporteert omzetgroei van 40,6% in de eerste helft van 2026, breidt de grootste wegwerphandschoenencapaciteit ter wereld uit tot 107 miljard stuks (PR Newswire)
- — INTCO Medical distinguée dans le « S&P Global Sustainability Yearbook » (édition chinoise) 2025 pour ses progrès en matière d'ESG (PR Newswire)
Analysis — what this means
Sectors affected
- medical disposable gloves
- healthcare supply chain
- raw materials (nitrile, latex)
Historical parallels
- Global glove demand surge during the COVID‑19 pandemic (2020‑2021)
- Hartalega’s capacity expansion announced in 2021
Key entities
Sources
Open the full interactive case file on Beyond →